Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 62, pseudogene (RN7SL62P)

Target
RN7SL62P
Molecular classification
Non-coding RNA pseudogene, Pseudogene, Retroelements-derived pseudogene
01

Overview

RN7SL62P is a non-functional pseudogene in the human genome representing a defunct copy of a gene encoding 7SL RNA, a critical RNA component of the signal recognition particle (SRP) ribonucleoprotein complex. While functional 7SL RNA is involved in co-translational targeting of proteins to the endoplasmic reticulum, pseudogenes like RN7SL62P usually arise through reverse transcription and genomic integration of RNA molecules. They are typically characterized by their lack of functional gene products and their frequent truncation or mutation relative to their parent sequence[1][4][7]. Pseudogenes are generally nonfunctional; however, rare regulatory functions for pseudogenes are described in other contexts, though none are known for RN7SL62P. There is no evidence that RN7SL62P is expressed or has a known regulatory or disease-associated role. While parental 7SL RNA or its derivatives may be implicated in cancer or neurodegenerative disease, there is no specific role described for RN7SL62P[1][5]. Most pseudogenes, including this one, are not considered therapeutic targets nor are they involved in known drug interactions. Pseudogenes are commonly found in the genome, often created by retrotransposition or gene duplication, but lack protein-coding potential or regulatory activity unless specifically shown otherwise[4][7]. 7SL RNA pseudogenes, including RN7SL62P, are numerous and typically lack the structural integrity needed for SRP function[7]. Any functional or disease relevance described for 7SL RNA or signal recognition particle does not apply to RN7SL62P[5][1].

Other names
RN7SL62P7SL RNA pseudogene 627SL cytoplasmic 62 pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 62, pseudogene (RN7SL62P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 62, pseudogene (RN7SL62P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call